Skip to main content
. 2012 Feb 9;12(3):505–521. doi: 10.1016/j.meegid.2012.01.011

Table 2.

Major advantage and disadvantages of various microarray formats for diagnostic purposes⁎⁎.

Format Supplier Advantages Disadvantages
Printed arrays In-house manufacture by a core facility
NimbleGen (Roche)
Agilent
  • Inexpensive

  • Simple to manufacture

  • Flexibility to change spot probes as required

  • Assay steps manual

  • Need reliable access to a core facility(dust, humidity and temperature controlled)

  • Little supervision over quality control of manufacture

  • Requires extensive in-house probe design and manufacture

  • Requires expensive assay validation

  • Requires access to in-house bioinformatics to analyze and assess quality of the data

  • Can be inflexibility to change assay probes as required

  • Can be non-conducive to user-defined development (exception: Agilent)

In-situ synthesized oligonucleotide arrays GeneChip®(Affymetrix)
  • Custom-assay production

  • Automated

  • Most expensive

  • High-density so (15,000 to >106) spot probes per assay

  • Complex to manufacture – probes chemically synthesized directly on quartz wafers

Electronic NanoChip® (Nanogen)
  • Electric fields promote active hybridization to nucleic acids onto a microelectronic device

  • Low-density (400 maximum) but adequate for diagnostic panel assays

  • Less expensive than high-density format

  • Allows flexible testing of multiple targets in a single sample or multiple samples on the same microarray cartridge

  • Commercially available products discontinued (2007)

Liquid-based suspension bead-based arrays Luminex Molecular Diagnostics
  • Probes or universal sequence tags are attached to spectrally unique microspheres; bead hybridization with fluorescently labeled target DNA measured by flow cytometry

  • Low-density (100 maximum) but adequate for diagnostic panel assays

  • Less expensive than high-density format

  • Only FDA-approved commercial assay (xTAG Respiratory Panel)

  • Most flexible, practical format for clinical use

  • Multitude of clinical applications

  • Requires careful validation of the positive fluorescent threshold for each analyte in a user-defined multiplex-bead-based assay

⁎⁎

Adapted from Miller and Tang (2009).